Literature DB >> 35900691

[Cannabis use in adolescents : Narrative Review and Position paper of the "Addiction Disorders in Adolescents" task force of the Austrian Society for Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy (ÖGKJP)].

Katrin Skala1, Thomas Trabi2, Martin Fuchs3, Ralf Gössler4, Christian-Wilhelm Haas-Stockmair5, Nicole Kriechbaumer6, Monika Leitner7, Nora Ortner3, Melanie Reiter3, Christian Müller8, Wolfgang Wladika9.   

Abstract

BACKGROUND: Cannabis is the illegal drug most frequently used by Minors in Austria. Due to the gradual decriminalization and legalization that has taken place in many European countries in recent years, the ÖGKJP would like to take a balanced and scientifically based stand on the complex issue of cannabis use and abuse among young people.
METHODS: The authors searched the medline for current studies using searches tailored to each specific subtopic. Furthermore, recognized compendiums were quoted.
RESULTS: While occasional recreational use of cannabis in adults with completed brain maturation and no risk profile for mental disorders is likely to be relatively harmless, early initiation of use with regular use and the increasingly available, highly potent cannabis varieties can lead to explicit and sometimes irreversible neurocognitive brain dysfunction.
CONCLUSION: Legalisation of cannabis consumption for minors needs to be objected to due to the risks of the expected damage in the area of brain development. At the same time, however, it is important to establish sensible legal regulations in order to be able to adequately counteract the fact that over 30% of all European young people occasionally consume cannabis. We are also clearly recommending to not criminalize cannabis users and provide necessary support to vulnerable and addicted cannabis users.
© 2022. The Author(s).

Entities:  

Keywords:  Brain development; Epidemiology; Minors; Substance use; Therapy

Year:  2022        PMID: 35900691     DOI: 10.1007/s40211-022-00424-1

Source DB:  PubMed          Journal:  Neuropsychiatr        ISSN: 0948-6259


  74 in total

Review 1.  CB2: a cannabinoid receptor with an identity crisis.

Authors:  Brady K Atwood; Ken Mackie
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 2.  Endocannabinoids at the synapse a decade after the dies mirabilis (29 March 2001): what we still do not know.

Authors:  Bradley E Alger
Journal:  J Physiol       Date:  2012-01-30       Impact factor: 5.182

Review 3.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 4.  Adolescence as a vulnerable period to alter rodent behavior.

Authors:  Miriam Schneider
Journal:  Cell Tissue Res       Date:  2013-02-22       Impact factor: 5.249

5.  Determination and characterization of a cannabinoid receptor in rat brain.

Authors:  W A Devane; F A Dysarz; M R Johnson; L S Melvin; A C Howlett
Journal:  Mol Pharmacol       Date:  1988-11       Impact factor: 4.436

6.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA.

Authors:  L A Matsuda; S J Lolait; M J Brownstein; A C Young; T I Bonner
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

7.  Cannabis with high cannabidiol content is associated with fewer psychotic experiences.

Authors:  Christian D Schubart; Iris E C Sommer; Willemijn A van Gastel; Rogier L Goetgebuer; René S Kahn; Marco P M Boks
Journal:  Schizophr Res       Date:  2011-05-17       Impact factor: 4.939

8.  Biological basis of cannabinoid medicines.

Authors:  Erik Keimpema; Vincenzo Di Marzo; Tibor Harkany
Journal:  Science       Date:  2021-12-16       Impact factor: 47.728

9.  History of cannabis and its preparations in saga, science, and sobriquet.

Authors:  Ethan B Russo
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

Review 10.  Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.

Authors:  Miriam Schneider
Journal:  Addict Biol       Date:  2008-06       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.